SCHEMBL6021897

SCHEMBL6021897

COc1ccccc1N1CCN(S(=O)(=O)c2ccc(CNC(=O)c3ccc(Cl)cc3)s2)CC1.O=C(NCc1ccc(S(=O)(=O)N2CCN(CC3CCCCC3)CC2)s1)c1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.54
DRD3 P35462 7/20 0.54
DRD4 P21917 5/20 0.54
MAPK9 P45984 1/20 0.51
MAPK10 P53779 1/20 0.51
KMT2A Q03164 2/20 0.50
LMNA P02545 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ADRA1A P35348 2/20 0.46
HTR1A P08908 2/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1B P35368 1/20 0.46
BCL2 P10415 1/20 0.44
BCL2L1 Q07817 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479867 0.90 KMT2A (0.61) DRD2DRD3DRD4MAPK9MAPK10
SCHEMBL3479855 0.88 MAPK9 (0.57) MAPK9MAPK10KMT2ALMNAMEN1
SCHEMBL7434542 0.88 DRD2 (0.58) DRD2DRD3DRD4MAPK9MAPK10
SCHEMBL4969645 0.87 MAPK9 (0.48) DRD2DRD4MAPK9MAPK10KMT2A
SCHEMBL2423386 0.80 MAPT (0.60) DRD2DRD3DRD4MAPK9MAPK10
SCHEMBL27657550 0.80 MAPK9 (0.57) DRD2DRD3DRD4MAPK9MAPK10
SCHEMBL2423962 0.79 MAPK9 (0.58) DRD2DRD3DRD4MAPK9MAPK10
SCHEMBL2424677 0.78 MAPK9 (0.58) DRD2DRD3DRD4MAPK9MAPK10
SCHEMBL2418948 0.77 MAPK9 (0.59) DRD2DRD3DRD4MAPK9MAPK10
SCHEMBL2425801 0.77 NPC1 (0.51) MAPK9MAPK10KMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218374-A1 PHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES Applied Research Systems ARS Holding N.V. (AN) 2002-07-03 EP claimed
WO-2001023378-A1 PHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-05 WO claimed
EP-1663193-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES Applied Research Systems ARS Holding N.V. (AN) 2006-06-07 EP disclosed
WO-2005025558-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES APPLIED RESERACH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO disclosed